Literature DB >> 23237699

OPTN/SRTR 2011 Annual Data Report: heart.

M Colvin-Adams1, J M Smith, B M Heubner, M A Skeans, L B Edwards, C Waller, J J Snyder, A K Israni, B L Kasiske.   

Abstract

Since 2005, the number of new active adult candidates on the heart transplant waiting list increased by 19.2%. The transplant rate peaked at 78.6 per 100 wait-list years in 2007, and declined to 67.8 in 2011. Wait-list mortality declined over the past decade, including among patients with a ventricular assist device at listing; in 2010 and 2011, the mortality rate for these patients was comparable to the rate for patients without a device. Median time to transplant was lowest for candidates listed in 2006-2007, and increased by 3.8 months for patients listed in 2010-2011. Graft survival has gradually improved over the past two decades, though acute rejection is common. Hospitalizations are frequent and increase in frequency over the life of the graft. In 2011, the rate of pediatric heart transplants was 124.6 per 100 patient-years on the waiting list; the highest rate was for patients aged less than 1 year. The pre-transplant mortality rate was also highest for patients aged less than 1 year. Short- and long-term graft survival has continued to improve. The effect on wait-list outcomes of a new pediatric heart allocation policy implemented in 2009 to reduce pediatric deaths on the waiting list cannot yet be determined. © Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23237699     DOI: 10.1111/ajt.12023

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  15 in total

1.  Optimal sampling time-point for cyclosporin A concentration monitoring in heart transplant recipients.

Authors:  Yixin Jia; Xu Meng; Yan Li; Chunlei Xu; Wen Zeng; Yuqing Jiao; Wei Han
Journal:  Exp Ther Med       Date:  2018-09-10       Impact factor: 2.447

Review 2.  What's new in clinical solid organ transplantation by 2013.

Authors:  Maurizio Salvadori; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2014-12-24

Review 3.  Heart transplantation: challenges facing the field.

Authors:  Makoto Tonsho; Sebastian Michel; Zain Ahmed; Alessandro Alessandrini; Joren C Madsen
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-01       Impact factor: 6.915

4.  Infectious Complications of Mechanical Circulatory Support (MCS) Devices.

Authors:  Stanley I Martin
Journal:  Curr Infect Dis Rep       Date:  2013-09-29       Impact factor: 3.725

5.  Cannabinoids inhibit T-cells via cannabinoid receptor 2 in an in vitro assay for graft rejection, the mixed lymphocyte reaction.

Authors:  Rebecca Hartzell Robinson; Joseph J Meissler; Jessica M Breslow-Deckman; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-04       Impact factor: 4.147

6.  Erythropoietin Receptor-Mediated Molecular Crosstalk Promotes T Cell Immunoregulation and Transplant Survival.

Authors:  Carolina Purroy; Robert L Fairchild; Toshiaki Tanaka; William M Baldwin; Joaquin Manrique; Joren C Madsen; Robert B Colvin; Alessandro Alessandrini; Bruce R Blazar; Miguel Fribourg; Chiara Donadei; Umberto Maggiore; Peter S Heeger; Paolo Cravedi
Journal:  J Am Soc Nephrol       Date:  2017-03-16       Impact factor: 10.121

7.  Everyday physical activity in ambulatory heart transplant candidates: the role of expected health benefits, social support, and potential barriers.

Authors:  Andreas Gerhardt; Gerdi Weidner; Mariel Grassmann; Heike Spaderna
Journal:  Int J Behav Med       Date:  2014-04

8.  Comparison of early versus delayed timing of left ventricular assist device implantation as a bridge-to-transplantation: An analysis of the UNOS dataset.

Authors:  Shuichi Kitada; P Christian Schulze; Zhezhen Jin; Kevin Clerkin; Shunichi Homma; Donna M Mancini
Journal:  Int J Cardiol       Date:  2015-11-09       Impact factor: 4.164

Review 9.  Selecting suitable solid organ transplant donors: Reducing the risk of donor-transmitted infections.

Authors:  Christopher S Kovacs; Christine E Koval; David van Duin; Amanda Guedes de Morais; Blanca E Gonzalez; Robin K Avery; Steven D Mawhorter; Kyle D Brizendine; Eric D Cober; Cyndee Miranda; Rabin K Shrestha; Lucileia Teixeira; Sherif B Mossad
Journal:  World J Transplant       Date:  2014-06-24

Review 10.  Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management.

Authors:  Nicole A Pilch; Lyndsey J Bowman; David J Taber
Journal:  Pharmacotherapy       Date:  2020-12-30       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.